Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer.
Jui-Ming LiuTien-Hsing ChenHeng-Chang ChuangChun-Te WuRen-Jun HsuPublished in: Prostate cancer and prostatic diseases (2018)
Statin use in T2DM patients receiving ADT for PCa had decreased risk of dementia, with statin adherence and intensity augmenting this benefit.